Continue Opportunistic Share Repurchases News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Continue opportunistic share repurchases. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Continue Opportunistic Share Repurchases Today - Breaking & Trending Today

HARMONY BIOSCIENCES PRELIMINARY UNAUDITED FOURTH QUARTER AND FULL YEAR 2023 NET PRODUCT REVENUE INCREASES MORE THAN 30 PERCENT; PROVIDES 2024 NET PRODUCT REVENUE GUIDANCE

/PRNewswire/ Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today reported preliminary, unaudited fourth quarter and full year 2023 net product revenue. ....

United States , Luis Sanay , Jeffreym Dayno , Drug Administration , Paragon Biosciences , Zynerba Pharmaceuticals , Exchange Commission , Prnewswire Harmony Biosciences Holdings Inc , Share Repurchase Program , Preliminary Net Revenue , Fourth Quarter , Full Year , Representing Growth , Product Revenue Projected Between , Common Stock Repurchase , Fourth Quarter Bringing , Continue Opportunistic Share Repurchases , Biosciences Holdings , Healthcare Conference , Harmony President , Product Revenue , Strong Growth , Net Revenue , Idiopathic Hypersomnia , Myotonic Dystrophy Type , Capital Allocation ,